eCite Digital Repository

The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective

Citation

Palmer, AJ and Brandt, A, The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective, Monaldi Archives for Chest Disease, 51, (4) pp. 279-288. ISSN 1122-0643 (1996) [Refereed Article]

Item Details

Item Type:Refereed Article
Research Division:Economics
Research Group:Applied Economics
Research Field:Health Economics
Objective Division:Health
Objective Group:Health and Support Services
Objective Field:Health Policy Economic Outcomes
Author:Palmer, AJ (Professor Andrew Palmer)
ID Code:74746
Year Published:1996
Deposited By:Research Division
Deposited On:2011-12-12
Last Modified:2011-12-13
Downloads:0

Repository Staff Only: item control page